Although the time course of Nrf2 stabilization and nuclear translocation indicated a rapid increase with a peak at approximately 6 h for DEM, and a slow but gradual rise triggered by NFT, maximal accumulation of Nrf2 protein, as well as the induction of GCLC and glutathione synthesis, were almost identical for both NFT and DEM after incubation periods of and beyond 24 h (Fig
& Chang, X
Counteraction by stable gastric pentadecapeptide BPC 157
Peptides for muscle growth and recovery overlap significantly with healing applications
The treatment was well tolerated, with no adverse events or clinically meaningful changes observed in vital signs, electrocardiograms, or laboratory biomarkers assessing cardiac, hepatic, renal, thyroid, or metabolic function
However, emerging KD modifications, such as the MAD or MCT-KD, have shown improved tolerability in some studies [199, 200], suggesting their potential for better long-term adherence